0001144204-15-003667.txt : 20150126 0001144204-15-003667.hdr.sgml : 20150126 20150126123638 ACCESSION NUMBER: 0001144204-15-003667 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150126 DATE AS OF CHANGE: 20150126 EFFECTIVENESS DATE: 20150126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSGENOMIC INC CENTRAL INDEX KEY: 0001043961 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 911789357 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-232336 FILM NUMBER: 15547648 BUSINESS ADDRESS: STREET 1: 12325 EMMET ST CITY: OMAHA STATE: NE ZIP: 68164 BUSINESS PHONE: 4027385480 MAIL ADDRESS: STREET 1: 12325 EMMET STREET CITY: OMAHA STATE: NE ZIP: 68164 D/A 1 primary_doc.xml X0707 D/A LIVE 0001043961 TRANSGENOMIC INC 12325 EMMET STREET OMAHA NE NEBRASKA 68164 (402) 452-5400 DELAWARE None None Corporation true Paul Kinnon c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Executive Officer Director President, Chief Executive Officer, Interim Chief Financial Officer and Secretary, Director Leon F. Richards c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Executive Officer Robert M. Patzig c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Doit L. Koppler, II c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director John D. Thompson c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Michael A. Luther c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Biotechnology Decline to Disclose 06b true 0001144204-15-002393 2014-12-31 false true true false 0 Craig-Hallum Capital Group LLC 121395 None None 222 SOUTH NINTH STREET, SUITE 350 MINNEAPOLIS MN MINNESOTA 55402 IL ILLINOIS MN MINNESOTA NJ NEW JERSEY NY NEW YORK false 1675000 1675000 0 false 8 46250 0 Craig-Hallum Capital Group LLC was issued an unsecured convertible promissory note in an aggregate principal amount of $46,250, which is convertible into shares of the common stock of Transgenomic, Inc., for acting as placement agent for the offering. 0 false TRANSGENOMIC INC /s/ Paul Kinnon Paul Kinnon President, CEO, Interim CFO & Secretary 2015-01-23